Medindia
Medindia LOGIN REGISTER
Advertisement

Boston Scientific Announces Enrollment of First Patient in Post-Approval Study for TAXUS Liberte Stent

Monday, January 4, 2010 Research News
Advertisement
Company to contribute data to industry-sponsored Dual Antiplatelet Therapy (DAPT) Study

CONTACT:

Paul Donovan

508-650-8541 (office)

508-667-5165 (mobile)

Media Relations

Boston Scientific Corporation

Larry Neumann

508-650-8696 (office)

Investor Relations

Boston Scientific Corporation

Sponsored Post and Backlink Submission


Latest Press Release on Research News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close